Accurate and timely diagnosis of the tropic disease visceral leishmaniasis (VL) is one of the pillars for reducing VL deaths. Currently available serological tests for diagnosing VL vary widely in their performance and may, ...
Jul 18, 2019
0
3
Women in Indian states with endemic visceral leishmaniasis—also known as Kala Azar—should be encouraged to seek care for persistent fever without delay. Raised awareness about the disease and its symptoms, and the prioritization ...
Jun 27, 2019
0
0
Paromomysin-based topical treatments were shown to be effective in curing cutaneous leishmaniasis (CL), according to a randomized, double blind study conducted in Panama and published with PLOS Neglected Tropical Diseases.
May 2, 2019
0
1
The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative (DNDi), in partnership with Médecins Sans Frontières (MSF), the University of Gondar, and Addis Ababa University, open ...
Jan 17, 2019
0
1
Coinfection with visceral leishmaniasis (VL) and human immunodeficiency virus (HIV) has been observed in at least 35 countries on four continents and requires special case management. Currently, the World Health Organization ...
Jan 17, 2019
0
1
Current treatment options for the parasitic disease leishmaniasis are largely ineffective, expensive, and tend to be plagued by resistant parasites and side effects. Now, researchers reporting in PLOS Neglected Tropical Diseases ...
Dec 6, 2018
0
0
Cutaneous leishmaniasis (CL) is a parasitic infection caused by Leishmania parasite. CL cases have increased dramatically in Syria and neighboring countries due to conflict-related displacement of Syrians. A study published ...
Nov 21, 2018
0
1
Visceral leishmaniasis (VL) is a life-threatening disease transmitted by the bite of a sand fly. Between 3,700 to 7,400 people in Ethiopia are infected annually, particularly in the northern, agricultural regions with favorable ...
Nov 8, 2018
0
3
Professor Simona Stäger and her team at INRS have discovered a mechanism that causes the body to sabotage its own defenses against infection by visceral leishmaniasis, a fatal tropical disease. This discovery could help ...
Aug 1, 2018
0
2
A new preclinical candidate drug with the potential to treat visceral leishmaniasis, one of the world's major neglected diseases, has been discovered through a close collaboration between the University of Dundee, GSK and ...
Jul 25, 2018
0
23
